Gain mechanistic insights and streamline your path to the clinic with Nuvisan’s integrated pharmacology and biomarker solutions.
From target validation to proof-of-concept studies, our expert teams provide end-to-end support, guiding your pathway to innovative therapies.
Our state-of-the-art platforms and tailored study designs deliver robust data and translational insights, empowering you to make informed decisions faster.
Leverage our broad therapeutic area expertise to efficiently identify and characterise preclinical candidates, accelerating their progression into the clinic.
Nuvisan offers a comprehensive suite of integrated services to accelerate drug discovery, spanning from early target identification to advanced preclinical development. Our expertise covers multi-omics profiling, pharmacology and disease-focused research, supporting both small molecules and advanced therapies.
Key offerings include:
Nuvisan offers actionable data, scientific rigor and a clear path to clinical success.
Unlock the power of integrated omics and biomarker solutions to drive your drug discovery forward. Nuvisan combines genomics, transcriptomics, proteomics and metabolomics to help provide a comprehensive understanding of disease mechanisms and drug effects.
Key features:
From sample prep to data interpretation, our end-to-end services deliver actionable results that can help accelerate your discovery pipeline and support translational research.
Help ensure your drug discovery is built on a solid foundation with robust target identification and validation. Nuvisan leverages cutting-edge techniques to discover and confirm druggable targets with high therapeutic potential.
Key features:
Our multidisciplinary team guides you from hypothesis generation to proof-of-concept, enabling informed, data-driven decisions.
Advance your pipeline with physiologically relevant cell-based assays tailored to your targets and therapeutic area. Nuvisan’s platform delivers high-quality data for every stage of drug discovery.
Key features:
Our assays support hit identification, lead optimisation and safety assessment, helping ensure reliable, reproducible results.
Nuvisan´s in vivo pharmacology services provide critical data for drug discovery and preclinical development using state-of-the-art animal models and technologies.
Key features:
Our experienced team helps ensure rigorous study design, animal welfare and regulatory compliance for robust, translational insights.
Benefit from Nuvisan´s expertise across a wide range of therapeutic areas, with integrated services tailored to your indication.
Key features:
Our holistic approach helps ensure that your project receives deep disease insight and a clear path to clinical success.
